Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ABT-737 |
Trade Name | |
Synonyms | ABT737|ABT 737 |
Drug Descriptions |
ABT-737 is a BH3 mimetic, which targets Bcl2, Bcl-xl, and Bcl-w to induce apoptosis (PMID: 32623836). |
DrugClasses | BCL-XL inhibitor 14 BCL2 inhibitor 26 |
CAS Registry Number | 852808-04-9 |
NCIT ID | C114384 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABT-737 | ABT-737 | 0 | 0 |
ABT-737 + Anti-CD19 CAR-T cells | ABT-737 Anti-CD19 CAR-T cells | 0 | 0 |
ABT-737 + AZD4547 | ABT-737 AZD4547 | 3 | 0 |
ABT-737 + AZD8055 + Trametinib | ABT-737 AZD8055 Trametinib | 0 | 0 |
ABT-737 + Cisplatin | ABT-737 Cisplatin | 0 | 0 |
ABT-737 + CYC065 | ABT-737 CYC065 | 0 | 0 |
ABT-737 + Dactolisib | ABT-737 Dactolisib | 1 | 0 |
ABT-737 + Dactolisib + Trametinib | ABT-737 Dactolisib Trametinib | 0 | 0 |
ABT-737 + Doxorubicin | ABT-737 Doxorubicin | 0 | 0 |
ABT-737 + Gemcitabine | ABT-737 Gemcitabine | 0 | 0 |
ABT-737 + Infigratinib | ABT-737 Infigratinib | 3 | 0 |
ABT-737 + MK2206 + Trametinib | ABT-737 MK2206 Trametinib | 0 | 0 |
ABT-737 + Oxaliplatin | ABT-737 Oxaliplatin | 0 | 0 |
ABT-737 + PD173074 | ABT-737 PD173074 | 3 | 0 |
ABT-737 + Perifosine | ABT-737 Perifosine | 0 | 0 |
ABT-737 + Sapanisertib | ABT-737 Sapanisertib | 1 | 0 |
ABT-737 + Vorinostat | ABT-737 Vorinostat | 0 | 0 |